Innovative ligands for nuclear receptors to eradicate cancer relapse

Obermair, Gerald (CoI)
Ellinger, Isabella (PI)

Department of Physiology

Medical University of Vienna
University of Wrocław
Ben-Gurion University of the Negev
University of Santiago de Compostela
TissueGnostics GmbH
University of Warsaw
Medical University of Warsaw
Trinity College Dublin
Biolution
Mag. Franz Tettinger
Janssen Sciences Ireland UC
Physiolution
Pikralida
Queensland University of Technology
Selvita
Shaare Zedek Medical Center
Wannaboo
University of Birmingham

Short title	eRaDicate
Acronym	eRaDicate
Status	Active
Effective start/end date	01.01.2024 → 31.12.2027

Collaborative partners

Karl Landsteiner University of Health Sciences
Medical University of Vienna (lead)
University of Wrocław
Ben-Gurion University of the Negev
University of Santiago de Compostela
TissueGnostics GmbH
University of Warsaw
Medical University of Warsaw
Trinity College Dublin
Biolution
Mag. Franz Tettinger
Janssen Sciences Ireland UC
Physiolution
Pikralida
Queensland University of Technology
Selvita
Shaare Zedek Medical Center
Wannaboo
University of Birmingham

Funding

Horizon Europe Framework Programme

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

SDG 3 Good Health and Well-being